Characterization of the IncFII-IncFIB(pB171) Plasmid Carrying bla NDM-5 in Escherichia coli ST405 Clinical Isolate in Japan.
Yoko TakayamaTsuyoshi SekizukaHidehito MatsuiYuzuru AdachiRyotaro EdaShin NihonyanagiTatsuhiko WadaMari MatsuiSatowa SuzukiMasashi TakasoHidero KitasatoMakoto KurodaHideaki HanakiPublished in: Infection and drug resistance (2020)
We characterized a novel Inc replicon plasmid (IncFII-IncFIB[pB171]) carrying bla NDM-5 and its host E. coli strain. NDMs are associated with a high risk of infection worldwide because of their antibiotic resistance and untreatable and hard-to-treat infections. Other patients in the hospital showed negative results for carbapenem-resistant Enterobacteriaceae. As NDM-producing strains are only sporadically detected in Japan, attention should be provided to the community prevalence of NDM-producing E. coli strains to prevent nosocomial infections.
Keyphrases
- klebsiella pneumoniae
- escherichia coli
- end stage renal disease
- healthcare
- biofilm formation
- heavy metals
- newly diagnosed
- ejection fraction
- chronic kidney disease
- risk factors
- prognostic factors
- mental health
- working memory
- peritoneal dialysis
- risk assessment
- emergency department
- patient reported outcomes
- drug resistant
- aqueous solution